Oropharyngeal dysphagia and cachexia: Intertwined in head and neck cancer.

Background: This study aims to investigate the relationship between cancer cachexia and oropharyngeal dysphagia (OD) in patients with head and neck cancer (HNC) prior to chemoradiotherapy or bioradiotherapy (CRT/BRT). Methods: A prospective cohort study with patients with HNC undergoing CRT/BRT (2018–2021) was conducted. Body composition and skeletal muscle function were evaluated using bioelectrical impedance analysis, handgrip strength, and the short physical performance battery (SPPB). The M. D. Anderson Dysphagia Inventory (MDADI), Eating Assessment Tool (EAT)‐10 questionnaire, and patient characteristics were collected. A standardized videofluoroscopic swallowing study was offered to patients. Results: Sixty‐six patients were included. Twenty‐six patients scored EAT‐10 ≥ 3 and seventeen were cachectic. ACE‐27 score >1, cachexia, abnormal SPPB‐derived repeated chair‐stand test, lower MDADI scores, and higher overall stage grouping showed potential predictive value (p ≤ 0.10) for EAT‐10 ≥ 3. Using multivariable regression analysis, only cachexia remained a significant predictor of EAT‐10 ≥ 3 (HR 9.000 [95%CI 2.483–32.619], p = 0.001). Conclusion: Cachexia independently predicted the presence of patient‐reported OD. [ABSTRACT FROM AUTHOR]